{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:32Z","timestamp":1788416012952,"version":"build-2803163510"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>As the inheritance, innovation, and development of TCM advance, medical insurance reimbursement policies are intended to improve access, guide service structure, and support high-quality development. This study examines the implementation progress, policy constraints, and optimization paths of TCM reimbursement reform in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study analyzes publicly available national and regional policy documents, together with secondary literature, to synthesize the policy design, implementation arrangements, and evidence boundaries of TCM reimbursement reform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The policy corpus suggests that national and local governments have progressively expanded insurance support for eligible TCM institutions, techniques, and decocted herbal medicines, creating institutional conditions for broader reimbursement arrangements. At the implementation level, some regions have explored TCM outpatient syndrome-differentiation fees, DRG-based incentives, and outpatient global-budget management. However, current payment rules still do not fully align with TCM diagnostic and treatment characteristics. Key issues include incomplete recognition of syndrome differentiation and treatment value under DRG payment, low TCM service prices, insufficient reimbursement levels, static control of TCM decoction pieces costs, tension between zero-markup policies and payment reform, and immature quality-evaluation mechanisms under centralized procurement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Based on these findings, the study proposes refining TCM-specific payment and pricing mechanisms, adjusting disease grouping and payment rules, dynamically revising cost-control standards, coordinating markup reform with compensation policies, and developing quality grading and \u201chigher quality, higher price\u201d mechanisms for herbal materials. Because the evidence is primarily policy-level, the study identifies policy instruments and implementation pathways rather than causal effects on service utilization, patient access, fund expenditure, or clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1923879","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:22:35Z","timestamp":1788412955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Traditional Chinese medicine reimbursement reform in China: implementation progress, policy constraints, and optimization strategies"],"prefix":"10.3389","volume":"14","author":[{"given":"Fazheng","family":"Zhao","sequence":"first","affiliation":[{"name":"Zhejiang Cultural Research Institute of Chinese Medicine, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichi","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Humanities and Management, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[{"name":"College of Humanities and Management, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.healthpol.2008.09.003","article-title":"Traditional Chinese medicine in the Chinese health care system","volume":"90","author":"Xu","year":"2009","journal-title":"Health Policy"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"9313491","DOI":"10.1155\/2020\/9313491","article-title":"Is traditional Chinese medicine \u201cmainstream\u201d in China? Trends in traditional Chinese medicine health resources and their utilization in traditional Chinese medicine hospitals from 2004 to 2016","volume":"2020","author":"Shi","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(15)00342-6","article-title":"Consolidating the social health insurance schemes in China: towards an equitable and efficient health system","volume":"386","author":"Meng","year":"2015","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/S0140-6736(08)61368-9","article-title":"Reform of how health care is paid for in China: challenges and opportunities","volume":"372","author":"Hu","year":"2008","journal-title":"Lancet"},{"key":"ref5","year":"2021"},{"key":"ref6","year":"2022"},{"key":"ref7","year":"2025"},{"key":"ref8","year":"2021"},{"key":"ref9","year":"2021"},{"key":"ref10","year":"2022"},{"key":"ref11","year":"2023"},{"key":"ref12","year":"2024"},{"key":"ref13","year":"2024"},{"key":"ref14","year":"2024"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2471\/BLT.12.115931","article-title":"Hospital payment systems based on diagnosis-related groups: experiences in low-and middle-income countries","volume":"91","author":"Mathauer","year":"2013","journal-title":"Bull World Health Organ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12913-020-4957-5","article-title":"The effects of diagnosis-related groups payment on hospital healthcare in China: a systematic review","volume":"20","author":"Zou","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12939-020-01326-w","article-title":"Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China","volume":"19","author":"Jiang","year":"2020","journal-title":"Int J Equity Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/heapol\/czz053","article-title":"\u201cThe biggest reform to China's health system\u201d: did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals?","volume":"34","author":"Shi","year":"2019","journal-title":"Health Policy Plan"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e011535","DOI":"10.1136\/bmjgh-2022-011535","article-title":"Improving access to medicines and beyond: the national volume-based procurement policy in China","volume":"8","author":"Zhu","year":"2023","journal-title":"BMJ Glob Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e005519","DOI":"10.1136\/bmjgh-2021-005519","article-title":"Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China","volume":"6","author":"Yuan","year":"2021","journal-title":"BMJ Glob Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"9123103","DOI":"10.1155\/2016\/9123103","article-title":"Current status of standardization of traditional Chinese medicine in China","volume":"2016","author":"Wang","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jcma.2016.11.009","article-title":"Raman spectroscopy in quality control of Chinese herbal medicine","volume":"80","author":"Chen","year":"2017","journal-title":"J Chin Med Assoc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1923879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:22:36Z","timestamp":1788412956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1923879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2026.1923879"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1923879","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1923879"}}